Edelweiss Capital Research

Home
Archive
About

Sitemap - 2022 - Edelweiss Capital Research

#39 Compounding human capital

#38 Show me the value

#37 A breeding ground for the GFC: from Volcker to Bernanke

#36 Management & incentive schemes III: the good

#35 Management & incentive schemes II: the bad

#34 Management & incentive schemes I: the ugly

#33 The Chinese straw man fallacy

#32 Reinvesting beyond limits

#31 Disruption gets too much attention

#30 Reading for a new world

#29 Adobe: creativity at scale

#28 All Blacks, culture and investing

#27 The never-ending dream

#26 Compounding value: Part III

#25 Compounding value: Part II

#24 Compounding value: Part I

#23 Google: the modern 5th Avenue Real Estate

#22 Portfolio management III: capital allocation

#21 Portfolio management II: position sizing

#20 Portfolio management I: portfolio size

#19 Meta: short term narrative vs long term reality

#18 Siren call: share repurchases

#17 An economic framework for investing: the Austrian School

#16 Making sense of Bitcoin

#15 Standing on the shoulders of giants

#14 Summer reads

#13 Apple's adventures in wonderland

#12 Topicus: a Dutch serial compounder?

#11 Value speculators

#10 The Big Long

#9 Rebel capital allocators (Part III)

#8 When markets behave irrationally

#7 Rebel capital allocators (Part II)

#6 Rebel capital allocators (Part I)

#5 Inflation and the inevitable hangover

#4 Incentives, innovation & management

#3 Investing in China?

#2 Semler Scientific: Q4 update

#1 Semler Scientific Inc

© 2023 Edelweiss Capital
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great writing